Pentazocine and naloxone (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Pentazocine and naloxone drug offered from Actavis Pharma, Inc.. This Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Pentazocine hydrochloride and naloxone hydrochloride |
| SUBSTANCE NAME: | PENTAZOCINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1997-01-21 |
| END MARKETING DATE: | 0000-00-00 |
Pentazocine and naloxone HUMAN PRESCRIPTION DRUG Details:
| Item Description | Pentazocine and naloxone from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 50; .5(mg/1; mg/1) |
| START MARKETING DATE: | 1997-01-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-0395_5d4742dc-33c0-4b5c-a995-1b0d80284839 |
| PRODUCT NDC: | 0591-0395 |
| APPLICATION NUMBER: | ANDA074736 |
Other PENTAZOCINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
